These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

436 related items for PubMed ID: 15841107

  • 1. Administration of SCH 23390 into the medial prefrontal cortex blocks the expression of MDMA-induced behavioral sensitization in rats: an effect mediated by 5-HT2C receptor stimulation and not by D1 receptor blockade.
    Ramos M, Goñi-Allo B, Aguirre N.
    Neuropsychopharmacology; 2005 Dec; 30(12):2180-91. PubMed ID: 15841107
    [Abstract] [Full Text] [Related]

  • 2. Dopamine D1 receptor activation in the medial prefrontal cortex prevents the expression of cocaine sensitization.
    Sorg BA, Li N, Wu WR.
    J Pharmacol Exp Ther; 2001 May; 297(2):501-8. PubMed ID: 11303036
    [Abstract] [Full Text] [Related]

  • 3. Blockade of D1 dopamine receptors in the medial prefrontal cortex attenuates amphetamine- and methamphetamine-induced locomotor activity in the rat.
    Hall DA, Powers JP, Gulley JM.
    Brain Res; 2009 Dec 01; 1300():51-7. PubMed ID: 19733155
    [Abstract] [Full Text] [Related]

  • 4. Hyperlocomotive and discriminative stimulus effects of cocaine are under the control of serotonin(2C) (5-HT(2C)) receptors in rat prefrontal cortex.
    Filip M, Cunningham KA.
    J Pharmacol Exp Ther; 2003 Aug 01; 306(2):734-43. PubMed ID: 12721337
    [Abstract] [Full Text] [Related]

  • 5. 3,4-Methylenedioxymethamphetamine (MDMA) enhances the release of acetylcholine by 5-HT4 and D1 receptor mechanisms in the rat prefrontal cortex.
    Nair SG, Gudelsky GA.
    Synapse; 2005 Dec 15; 58(4):229-35. PubMed ID: 16206181
    [Abstract] [Full Text] [Related]

  • 6. Studies on the role of dopamine D1 receptors in the development and expression of MDMA-induced behavioral sensitization in rats.
    Ramos M, Goñi-Allo B, Aguirre N.
    Psychopharmacology (Berl); 2004 Dec 15; 177(1-2):100-10. PubMed ID: 15338099
    [Abstract] [Full Text] [Related]

  • 7. Effects of SKF-38393, a dopamine D1 receptor agonist on expression of amphetamine-induced behavioral sensitization and expression of immediate early gene arc in prefrontal cortex of rats.
    Moro H, Sato H, Ida I, Oshima A, Sakurai N, Shihara N, Horikawa Y, Mikuni M.
    Pharmacol Biochem Behav; 2007 May 15; 87(1):56-64. PubMed ID: 17499349
    [Abstract] [Full Text] [Related]

  • 8. Ibotenic acid lesions of the medial prefrontal cortex block the development and expression of 3,4-methylenedioxymethamphetamine-induced behavioral sensitization in rats.
    Ramos M, Goñi-Allo B, Aguirre N.
    Behav Brain Res; 2005 May 28; 160(2):304-11. PubMed ID: 15863226
    [Abstract] [Full Text] [Related]

  • 9. Sensitization to MDMA locomotor effects and changes in the functionality of 5-HT(2A) and D₂ receptors in mice.
    Varela MJ, Brea J, Loza MI, Maldonado R, Robledo P.
    Behav Pharmacol; 2011 Aug 28; 22(4):362-9. PubMed ID: 21712712
    [Abstract] [Full Text] [Related]

  • 10. 3,4-N-methlenedioxymethamphetamine-induced hypophagia is maintained in 5-HT1B receptor knockout mice, but suppressed by the 5-HT2C receptor antagonist RS102221.
    Conductier G, Crosson C, Hen R, Bockaert J, Compan V.
    Neuropsychopharmacology; 2005 Jun 28; 30(6):1056-63. PubMed ID: 15668722
    [Abstract] [Full Text] [Related]

  • 11. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.
    Schreiber R, Brocco M, Audinot V, Gobert A, Veiga S, Millan MJ.
    J Pharmacol Exp Ther; 1995 Apr 28; 273(1):101-12. PubMed ID: 7714755
    [Abstract] [Full Text] [Related]

  • 12. Agonist efficacy and the behavioral effects of dopamine D1 receptor ligands: drug interaction studies in squirrel monkeys.
    Bergman J, Spealman RD, Madras BK, Rosenzweig-Lipson S.
    J Pharmacol Exp Ther; 1996 Mar 28; 276(3):942-50. PubMed ID: 8786574
    [Abstract] [Full Text] [Related]

  • 13. Risperidone attenuates and reverses hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats.
    Shioda K, Nisijima K, Yoshino T, Kuboshima K, Iwamura T, Yui K, Kato S.
    Neurotoxicology; 2008 Nov 28; 29(6):1030-6. PubMed ID: 18722468
    [Abstract] [Full Text] [Related]

  • 14. 5-HT2C receptor agonists attenuate pain-related behaviour in a rat model of trigeminal neuropathic pain.
    Nakai K, Nakae A, Oba S, Mashimo T, Ueda K.
    Eur J Pain; 2010 Nov 28; 14(10):999-1006. PubMed ID: 20488736
    [Abstract] [Full Text] [Related]

  • 15. Cooperative activation of D1-like and D2-like dopamine receptors in the nucleus accumbens shell is required for the reinstatement of cocaine-seeking behavior in the rat.
    Schmidt HD, Pierce RC.
    Neuroscience; 2006 Oct 13; 142(2):451-61. PubMed ID: 16844308
    [Abstract] [Full Text] [Related]

  • 16. In vivo evidence that constitutive activity of serotonin2C receptors in the medial prefrontal cortex participates in the control of dopamine release in the rat nucleus accumbens: differential effects of inverse agonist versus antagonist.
    Leggio GM, Cathala A, Neny M, Rouge-Pont F, Drago F, Piazza PV, Spampinato U.
    J Neurochem; 2009 Oct 13; 111(2):614-23. PubMed ID: 19702657
    [Abstract] [Full Text] [Related]

  • 17. Blockade of the dorsal hippocampal dopamine D1 receptors inhibits the scopolamine-induced state-dependent learning in rats.
    Piri M, Rostampour M, Nasehi M, Zarrindast MR.
    Neuroscience; 2013 Nov 12; 252():460-7. PubMed ID: 23933216
    [Abstract] [Full Text] [Related]

  • 18. Dopamine in the prefrontal cortex regulates rats behavioral flexibility to changing reward value.
    Winter S, Dieckmann M, Schwabe K.
    Behav Brain Res; 2009 Mar 02; 198(1):206-13. PubMed ID: 19041903
    [Abstract] [Full Text] [Related]

  • 19. Catalepsy-associated behavior induced by dopamine D1 receptor antagonists and partial dopamine D1 receptor agonists in squirrel monkeys.
    Rosenzweig-Lipson S, Bergman J.
    Eur J Pharmacol; 1994 Aug 01; 260(2-3):237-41. PubMed ID: 7988649
    [Abstract] [Full Text] [Related]

  • 20. Selective dopamine antagonist pretreatment on the antiparkinsonian effects of benzazepine D1 dopamine agonists in rodent and primate models of Parkinson's disease--the differential effects of D1 dopamine antagonists in the primate.
    Gnanalingham KK, Hunter AJ, Jenner P, Marsden CD.
    Psychopharmacology (Berl); 1995 Feb 01; 117(4):403-12. PubMed ID: 7604140
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.